Found 3 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Cyclin-dependent kinase 4
(Homo sapiens (Human)) | BDBM444503
(US10662186, Compound 31)Show SMILES Cc1nc2c(F)cc(cc2n1C1CC1)-c1nc(Nc2ccc3CN(CCc3n2)C(=O)CC2CC(O)C2)ncc1F |(7.29,3.08,;5.75,3.08,;4.84,1.83,;3.38,2.31,;2.05,1.54,;2.05,,;.71,2.31,;.71,3.85,;2.05,4.62,;3.38,3.85,;4.84,4.33,;5.24,5.81,;4.15,6.9,;6.73,6.21,;-.62,4.62,;-1.95,3.85,;-3.29,4.62,;-4.62,3.85,;-4.62,2.31,;-3.29,1.54,;-3.29,,;-4.62,-.77,;-4.62,-2.31,;-5.96,-3.08,;-7.29,-2.31,;-7.29,-.77,;-5.96,,;-5.96,1.54,;-5.96,-4.62,;-7.29,-5.39,;-4.62,-5.39,;-3.22,-4.76,;-2.9,-3.26,;-1.39,-3.58,;-.09,-2.74,;-1.68,-4.92,;-3.29,6.16,;-1.95,6.93,;-.62,6.16,;.71,6.93,)| Show InChI InChI=1S/C29H29F2N7O2/c1-15-33-28-21(30)11-18(12-24(28)38(15)19-3-4-19)27-22(31)13-32-29(36-27)35-25-5-2-17-14-37(7-6-23(17)34-25)26(40)10-16-8-20(39)9-16/h2,5,11-13,16,19-20,39H,3-4,6-10,14H2,1H3,(H,32,34,35,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 2.35 | n/a | n/a | n/a | n/a | n/a | n/a |
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.
US Patent
| Assay Description
1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100... |
US Patent US10662186 (2020)
BindingDB Entry DOI: 10.7270/Q2GX4FKS |
More data for this
Ligand-Target Pair | |
Cyclin-dependent kinase 6
(Homo sapiens (Human)) | BDBM444503
(US10662186, Compound 31)Show SMILES Cc1nc2c(F)cc(cc2n1C1CC1)-c1nc(Nc2ccc3CN(CCc3n2)C(=O)CC2CC(O)C2)ncc1F |(7.29,3.08,;5.75,3.08,;4.84,1.83,;3.38,2.31,;2.05,1.54,;2.05,,;.71,2.31,;.71,3.85,;2.05,4.62,;3.38,3.85,;4.84,4.33,;5.24,5.81,;4.15,6.9,;6.73,6.21,;-.62,4.62,;-1.95,3.85,;-3.29,4.62,;-4.62,3.85,;-4.62,2.31,;-3.29,1.54,;-3.29,,;-4.62,-.77,;-4.62,-2.31,;-5.96,-3.08,;-7.29,-2.31,;-7.29,-.77,;-5.96,,;-5.96,1.54,;-5.96,-4.62,;-7.29,-5.39,;-4.62,-5.39,;-3.22,-4.76,;-2.9,-3.26,;-1.39,-3.58,;-.09,-2.74,;-1.68,-4.92,;-3.29,6.16,;-1.95,6.93,;-.62,6.16,;.71,6.93,)| Show InChI InChI=1S/C29H29F2N7O2/c1-15-33-28-21(30)11-18(12-24(28)38(15)19-3-4-19)27-22(31)13-32-29(36-27)35-25-5-2-17-14-37(7-6-23(17)34-25)26(40)10-16-8-20(39)9-16/h2,5,11-13,16,19-20,39H,3-4,6-10,14H2,1H3,(H,32,34,35,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.84 | n/a | n/a | n/a | n/a | n/a | n/a |
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.
US Patent
| Assay Description
1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100... |
US Patent US10662186 (2020)
BindingDB Entry DOI: 10.7270/Q2GX4FKS |
More data for this
Ligand-Target Pair | |
Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM444503
(US10662186, Compound 31)Show SMILES Cc1nc2c(F)cc(cc2n1C1CC1)-c1nc(Nc2ccc3CN(CCc3n2)C(=O)CC2CC(O)C2)ncc1F |(7.29,3.08,;5.75,3.08,;4.84,1.83,;3.38,2.31,;2.05,1.54,;2.05,,;.71,2.31,;.71,3.85,;2.05,4.62,;3.38,3.85,;4.84,4.33,;5.24,5.81,;4.15,6.9,;6.73,6.21,;-.62,4.62,;-1.95,3.85,;-3.29,4.62,;-4.62,3.85,;-4.62,2.31,;-3.29,1.54,;-3.29,,;-4.62,-.77,;-4.62,-2.31,;-5.96,-3.08,;-7.29,-2.31,;-7.29,-.77,;-5.96,,;-5.96,1.54,;-5.96,-4.62,;-7.29,-5.39,;-4.62,-5.39,;-3.22,-4.76,;-2.9,-3.26,;-1.39,-3.58,;-.09,-2.74,;-1.68,-4.92,;-3.29,6.16,;-1.95,6.93,;-.62,6.16,;.71,6.93,)| Show InChI InChI=1S/C29H29F2N7O2/c1-15-33-28-21(30)11-18(12-24(28)38(15)19-3-4-19)27-22(31)13-32-29(36-27)35-25-5-2-17-14-37(7-6-23(17)34-25)26(40)10-16-8-20(39)9-16/h2,5,11-13,16,19-20,39H,3-4,6-10,14H2,1H3,(H,32,34,35,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 20.4 | n/a | n/a | n/a | n/a | n/a | n/a |
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.
US Patent
| Assay Description
1. Take 10 mM stock solution of the test compound, in 96-well compound plate, DMSO was used to dilute the compound to an initial concentration of 100... |
US Patent US10662186 (2020)
BindingDB Entry DOI: 10.7270/Q2GX4FKS |
More data for this
Ligand-Target Pair | |